Stem cell therapy is regenerative medicine. The body regrows or repairs tissue using stem cells injected at the site of disease.
At Native Stem Cell's Clinics, our treatment regimen is centered around the use of your stem cells from your body, specifically stem cells extracted from your bone marrow.
With ReVivaStem® — our exclusive stem-cell injection therapy procedure — you can replace lost cartilage in your knee, hip or shoulder using the healing power of your own body. Control and even reverse the damage of arthritis with ReVivaStem®.
Stem Cell Injection Therapy (BMAC)
As “unspecialized” cells, stem cells have the ability to develop into many different cell types in the body, including cartilage, which makes stem cell therapy the most promising treatment for many types of disease, including arthritis.
Stem cells are present in all of us. They have the ability to self-renew or differentiate. They’re continually replacing our other cells as they die off.
Stem cells can be found in the body’s fat tissue, bone and blood — but they are especially concentrated in bone marrow, where blood cells are made.
ReVivaStem® uses stem cells from bone marrow. This is known as bone-marrow aspirate concentrate, or BMAC. It is distinct from other less effective stem cell therapies.
Why BMAC?
BMAC stem cell injections — as opposed to stem cell injections from adipose (fat) tissue or from donated amniotic or placental tissue — are shown to be the most likely to help regrow lost cartilage in your joints.
Articular cartilage — the smooth, white tissue that covers the ends of bones in your knees, hips, shoulders and other joints — is called hyaline cartilage.
Hyaline cartilage is unique in its ability to carry the load and stress of repeated, daily use of these joints.
The ability of BMAC stem cells to assist in the formation of new, load-bearing articular cartilage is what sets it apart from other treatments.
Compare Treatment Options
| Feature | BMAC (Bone-Marrow Stem Cells) | PRP (Platelet-Rich Plasma) | Steroid Injection |
|---|---|---|---|
| Primary goal | Support tissue repair and cartilage health using marrow-derived cells | Calm inflammation and support healing with growth factors | Short-term inflammation and pain reduction |
| Typical use cases | Moderate arthritis, focal cartilage wear, joint degeneration | Tendon/ligament irritation, mild osteoarthritis, post-injury flares | Acute pain flares that need quick relief |
| Duration of effect | Months to years (varies by diagnosis and patient factors) | Weeks to months; sometimes in a short series | Often weeks |
| Source | Patient’s own bone marrow (concentrated) | Patient’s own blood (concentrated platelets) | Synthetic corticosteroid |
| Downtime | Light activity shortly after; follow your physician’s plan | Light activity shortly after; follow your physician’s plan | Usually minimal |
| Adjunct strategy | Often paired with PRP to support early and later phases | Can boost BMAC protocols or be used standalone | Standalone |
| Who decides? | Your physician will recommend options based on imaging, exam, activity goals, and overall health. | ||